Drugs / PUR003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00947687 | Jul → Sep 2009 | — | Pulmatrix Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00989521 Comparator | Dec 2009 → Oct 2011 | asthma, lung disorder | Pulmatrix Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PUR003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00989521 ↗ |
| Route | Inhaled | “delivered via inhalation” NCT00947687 ↗ |